Myrexis (FRA:R9M) Institutional Ownership : 2.00% (As of Sep. 25, 2024)

View and export this data going back to . Start your Free Trial

What is Myrexis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Myrexis's institutional ownership is 2.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Myrexis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Myrexis's Float Percentage Of Total Shares Outstanding is 79.61%.

Myrexis Institutional Ownership Historical Data

The historical data trend for Myrexis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis Institutional Ownership Chart

Myrexis Historical Data

The historical data trend for Myrexis can be seen below:

	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30
Institutional Ownership	43.00	2.00	4.00	4.00	2.00	2.00	2.00	2.00	2.00	2.00

Myrexis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Myrexis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020

Website

http://www.myrexis.com

Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis Headlines

No Headlines